Palatal Ulceration Associated with Ecstasy Consumption: An Emerging Clinical Alert
Y. de Lima Medeiros, L. V. Faria, D.A.A. Marlière, L. D. de Abreu Guimarães, M. F. de Carvalho
Indian Journal of Otolaryngology and Head & Neck Surgery March 30, 2026 DOI: 10.1007/s12070-026-06533-5 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | A 25-year-old man with an oral ulcer following ecstasy use |
| Interventions | Low-level laser therapy topical antiseptic gel |
| Duration | Resolution within five days |
| Topics | MDMA |
| Key findings | The authors report that holding an ecstasy tablet in the mouth caused a chemical burn on the soft palate that progressed to a painful ulceration within 12 hours. Treatment with low-level laser therapy and topical antiseptic gel led to complete clinical resolution within five days. They note that ecstasy-related oral ulceration is extremely rare, with only three previously reported cases, and that stigma may lead to underreporting or delayed disclosure. |
Abstract
Oral ulcerations associated with ecstasy (3,4-methylenedioxymethamphetamine - MDMA) use are extremely rare, with only three cases reported in the literature to date. A 25-year-old man presented with palatal pain upon awakening following a night of recreational activity. Initial examination revealed a small, centrally located erythematous plaque with a friable surface on the soft palate. Within 12 h, the lesion progressed to a painful ulceration with irregular margins and a white pseudomembrane. Detailed history-taking revealed recent ecstasy use, with the tablet retained in the oral cavity prior to swallowing. Based on clinical findings and patient history, a diagnosis of chemical burn related to ecstasy was established. Treatment consisted of low-level laser therapy, combined with topical antiseptic gel. Complete clinical resolution was observed within five days. The stigma surrounding illicit drug use frequently leads to underreporting or delayed disclosure, which may complicate diagnosis and management.
Comparable studies
Other case reports and case series on MDMA, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| 'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA Individuals whose deaths were associated with MDMA or MDEA use | 1987 | Case series | n = 5 |
| Pathology of deaths associated with "ecstasy" and "eve" misuse. Young white men aged 20 to 25 who died after using ring-substituted amphetamines (MDMA... | 1996 | Case series | n = 7 |
| 'Eve' and 'Ecstasy' Individuals who died after using MDMA or MDEA | 1987 | Case series | n = 5 |
| A Method of Conducting Therapeutic Sessions with MDMA Clients with clear therapeutic purpose, excluding those with serious functional... | 1998 | Case study | n = 2 |
| Diversity of Psychopathology Associated with use of 3,4-Methylenedioxymethamphetamine (‘Ecstasy’) Psychiatric patients presenting between 1990 and 1992 whose symptoms developed in the... | 1994 | Case series | n = 13 |